Course of glomerular filtration rate in albuminuric type 2 diabetic patients with or without diabetic glomerulopathy

Diabetes Care

Volumn 23, Issue SUPPL. 2, 2000, Pages

  Christensen, Per K ^a   Gall, Mari Anne ^a   Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTERIAL PRESSURE; CLINICAL ARTICLE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA CLEARANCE; PROGNOSIS; PROTEINURIA;

ALBUMINURIA; BIOPSY; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 0034079569     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Ballard DJ, Humphrey LL, Melton LJ III, Frohnert PP, Chu C-P, O'Fallon WM, Palumbo PJ: Epidemiology of persistent proteinuria in type II diabetes mellitus: population-based study in Rochester, Minnesota. Diabetes 37:405-412, 1988
2. Parving H-H, Østerby R, Anderson PW, Hsueh WA: Diabetic nephropathy. In The Kidney. Brenner BM, Ed. Philadelphia, WB Saunders, 1996, p. 1864
3. Eggers PW: Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 318:223-229, 1988
4. Rettig B, Teutsch SM: The incidence of end-stage renal disease in type I and type II diabetes mellitus. Diabet Nephropathy 3:26-27, 1984
5. Grenfell A, Bewick M, Parsons V, Snowden S, Taube D, Watkins PJ: Non-insulin-dependent diabetes and renal replacement therapy. Diabet Med 5:172-176, 1988
6. Ritz E, Stefanski A: Diabetic nephropathy in type II diabetes. Am J Kidney 27:167-194, 1996
7. Parving H-H, Smidt UM, Früsberg B, Bonnevie-Nielsen V, Andersen AR: A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20:457-461, 1981
8. Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, Ujihara U, Takahashi C, Omori Y: Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia 40:405-411, 1997
9. Molitch ME, DeFronzo RA, Tranz MJ, Keane WF, Mogensen CE, Parving H-H, Steffes MW: Diabetic nephropathy, Diabetes Care 20:S24-S27, 1997
10. Rossing P, Hommel E, Smidt UM, Parving H-H: Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42:715-719, 1993
11. Parving H-H, Rossing P, Hommel E, Smidt UM: Angiotensin converting enzyme inhibition in diabetic nephropathy: ten years experience. Am J Kidney Dis 26:99-107, 1995
12. Mulec H. Johnsen SA, Björck S: Long-term enalapril treatment in diabetic nephropathy. Kidney Int 45 (Suppl. 45):S141-S144, 1994
13. Breyer JA, Bain P, Evans JK, Nahman NS, Lewis E, Cooper ME, McGill JB, Berl T, the Collaborative Study Group: Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 50:1651-1658, 1996
14. Parving H-H, Gall M-A. Skott P, Jorgensen HE, Lokkegaard H, Jorgensen F, Nielsen B, Larsen S: Prevalence and cause of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41:758-762, 1992
15. Schwatz MM, Lewis EJ, Leonard-Martin T, Breyer Lewis J, Battle D, the Collaborative Study Group: Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. Nephrol Dial Transplant 13: 2547-2552, 1998
16. Cordonnier DJ, Pinel N, Barro C, Maynard C., Zaoui P, Halimi S, Hurault de Ligny B, Reznic Y, Simon D, Bilous RW: Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. J Am Soc Nephrol 10:1253-1263, 1999
17. Chung J, Sobin CH: Renal Disease, Classification and Atlas of Glomerular disease. Tokyo, Igaku-Shoin, 1982
18. Hommel E, Carstensen H, Skott P, Larsen S, Parving H-H: Prevalence and causes of microscopic haematuria in type I (insulin-dependent) diabetic patients with persistent proteinuria. Diabetologia 30:627-630, 1987
19. Larsen S: Immune deposits in generalized mesangioproliferative glomerulonephritis. Acta Pathol Microbiol Scand 86:543-552, 1978
20. Hother-Nielsen O, Faber O, Sorensen NS, Beck-Nielsen H: Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 11:537-537, 1988
21. Bröchner-Mortensen J, Rodbro P: Selection of routine method for determination of glomerular filtration rate in adult patients Scand J Clin Lab Invest 36:35-45, 1976
22. Bröchner-Mortensen J: A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30:271-274, 1972
23. Christensen C, Ørskov C: Rapid screening PEG radioimmunoassay for quantification of pathological microalbuminuria. Diab Nephropathy 3:92-94, 1984
24. Feldt-Rasmussen B, Dinesen B, Deckert M: Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45:539-544, 1985
25. Ullmann R, Bonitz K: Vollmechanisierte kinetische Messung von Kreatinin. Med Labor Bd 29:137-145, 1476
26. Østerby R, Gall M-A, Schmitz A, Nielsen FS, Nyberg G, Parving H-H: Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1064-1070, 1993
27. Skott P, Hommel E, Arnold-Larsen S, Parving H-H: Effect of carbonic anhydrase inhibitors on glomerular filtration rate in diabetic nephropathy. Br Med J 294:549, 1987
28. Skott P, Hommel E, Bruun NE, Arnold-Larsen S, Parving H-H: Effects of acetazolamide on kidney function in type 1 (insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 31:806-810, 1988
29. Fioretto P, Mauer SM, Brocco E, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G, Nosadini R: Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39:1569-1576, 1996
30. Olsen S, Mogensen CE: How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature. Diabetologia 39:1638-1645, 1996
31. Amoah E, Jeffrey GL, Malchoff CD, Sturgill BC, Kaiser DL, Bolton WK: Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction. Am J Nephrol 8:204-211, 1988
32. Carstens SA, Herbert LA, Garancis JC, Piering WF, Lemann J: Rapidly progressive glomerulonephritis superimposed on diabetic glomeruloselerosis. JAMA 247:1453-1457, 1982
33. Kasinath BS, Mujais SK, Spargo BH. Katz AI: Nondiabetic renal disease in patients with diabetes mellitus. Am J Med 75:613-617, 1983
34. Bjorck S, Mulec H, Johnsen SA, Nordén G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. BMJ 304: 339-343, 1992
35. Parving H-H, Smidt UM, Hommel F., Mathiesen ER, Rossing P, Nielsen FS, Gall M-A: Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Dis 22:188-195, 1993
36. Walker WG, Hermann J, Murphy RP, Russell RP: Prospective study of the impact of hypertension upon kidney function in diabetes mellitus. Nephron 55 (Suppl. 1):21-26, 1990
37. Gall M-A, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P, Beck-Nielsen H, Parving H-H: Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34:655-661, 1991
38. Marshall SM, Alberti KGMM: Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. QJ Med 70:61-71, 1989
39. Sasaki A, Horiuchi N, Hasagawa K, Uehara M: Persistent albuminuria as an index of diabetic nephropathy in type 2 diabetic patients in Osaka, Japan: incidence, risk factors, prognosis, and causes of death. Diabetes Res Clin Pract 7:299-306, 1989
40. Bakris GL, Coply JB, Vicknair N, Sadler R, Leugans S: Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy Kidney Int 50:1641-1650, 1996
41. Ravid M, Lang R, Rachmani R, Lishner M: Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. Arch Intern Med 156:286-289, 1996
42. Bakris GL, Mangrum A, Copley JB, Vicknair N, Sadler R: Effect of calcium channel or β-blockade on the progression of diabetic nephropathy in African Americans. Hypertension 29:744-750, 1997
43. Peterson JC, Adler S, Burkart JM, Greene T, Herbert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria, and the progression of renal disease: the modification of diet in renal disease study. Ann Intern Med 123: 754-762, 1995
44. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. N Engl J Mfd 335:1636-1642, 1996
45. Ravid M, Savin H, Lang R, Jutrin I, Ludvinovsky S, Lishner M: Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus: a 14-year follow-up report on 195 patients. Arch Intern Med 152:1225-1229, 1992
46. Nyberg G, Blohmé G, Nordén G: Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetologi 30:82-86, 1987
47. Alaveras A, Thomas SM, Sagriotis A, Viberti GC: Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant 12:71-74, 1997